RHY 1.64% 6.0¢ rhythm biosciences limited

Bescreened 10,000 patient tests /trial, page-18

  1. 280 Posts.
    lightbulb Created with Sketch. 95
    if Bescreened can manage to sell tests on the strength of a single dodgy tiny clinical trial and a few misleading investor presentations, all whilst their panel of bio markers relies on CEA, widely agreed to be unsuitable for population screening... then, actually, I'm feeling even more positive about Colostat's potential than I was before!
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
6.0¢
Change
-0.001(1.64%)
Mkt cap ! $14.91M
Open High Low Value Volume
6.1¢ 6.2¢ 6.0¢ $7.244K 119.2K

Buyers (Bids)

No. Vol. Price($)
1 54512 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.2¢ 144742 1
View Market Depth
Last trade - 15.39pm 09/07/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.